Faeth Therapeutics, Inc. (FTH)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 16 signals for Faeth Therapeutics, Inc.. Most notable: 2026-07-23: Filed 8-K disclosing director or officer change; 2026-09-17: Filed 8-K disclosing director or officer change; 2026-06-23: STEPHENSON BRIAN C (officer) bought $165k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Insider purchase
    STEPHENSON BRIAN C (officer) bought $103k of stock
  4. Insider purchase
    STEPHENSON BRIAN C (officer) bought $106k of stock
  5. Insider purchase
    STEPHENSON BRIAN C (officer) bought $105k of stock
  6. Insider purchase
    STEPHENSON BRIAN C (officer) bought $92k of stock
  7. Insider purchase
    STEPHENSON BRIAN C (officer) bought $78k of stock
  8. Insider purchase
    STEPHENSON BRIAN C (officer) bought $78k of stock
  9. Insider purchase
    STEPHENSON BRIAN C (officer) bought $73k of stock
  10. Insider purchase
    STEPHENSON BRIAN C (officer) bought $73k of stock
  11. Insider purchase
    STEPHENSON BRIAN C (officer) bought $165k of stock
  12. Insider purchase
    STEPHENSON BRIAN C (officer) bought $165k of stock
  13. Insider purchase
    STEPHENSON BRIAN C (officer) bought $77k of stock
  14. Insider purchase
    STEPHENSON BRIAN C (officer) bought $77k of stock
  15. Insider purchase
    Parikh Anand Kiran (director) bought $55k of stock
  16. Insider purchase
    Parikh Anand Kiran (director) bought $55k of stock
  17. Material 8-K filing
    Filed 8-K disclosing material agreement
  18. Material 8-K filing
    Filed 8-K disclosing director or officer change
  19. Material 8-K filing
    Filed 8-K disclosing director or officer change
  20. Material 8-K filing
    Filed 8-K disclosing director or officer change
  21. Insider purchase
    MILLENNIUM MANAGEMENT LLC (ten_percent_owner) bought $121k of stock
  22. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $121k of stock
  23. Insider purchase
    MILLENNIUM MANAGEMENT LLC (ten_percent_owner) bought $56k of stock
  24. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $56k of stock
  25. Insider buying cluster
    3 insiders bought $1.5M within 14 days
  26. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $62k of stock
  27. Insider purchase
    MILLENNIUM MANAGEMENT LLC (ten_percent_owner) bought $62k of stock
  28. Insider purchase
    ICS OPPORTUNITIES II LLC (ten_percent_owner) bought $130k of stock
  29. Insider purchase
    ICS OPPORTUNITIES II LLC (ten_percent_owner) bought $75k of stock
  30. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $75k of stock
  31. Insider purchase
    ICS OPPORTUNITIES II LLC (ten_percent_owner) bought $280k of stock
  32. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $280k of stock
  33. Insider purchase
    ICS OPPORTUNITIES II LLC (ten_percent_owner) bought $120k of stock
  34. Insider purchase
    ICS OPPORTUNITIES II LLC (ten_percent_owner) bought $75k of stock
  35. Insider purchase
    MILLENNIUM MANAGEMENT LLC; ICS OPPORTUNITIES II LLC; MILLENNIUM GROUP MANAGEMENT LLC; ENGLANDER ISRAEL A (ten_percent_owner) bought $75k of stock
  36. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change
  37. Material 8-K filing
    Filed 8-K disclosing director or officer change
  38. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-07-01STEPHENSON BRIAN CofficerP4,40023.4$102,960
2026-07-01STEPHENSON BRIAN CofficerP60024.22$14,532
2026-06-30STEPHENSON BRIAN CofficerP1,91022.95$43,835
2026-06-30STEPHENSON BRIAN CofficerP1,63823.88$39,115
2026-06-30STEPHENSON BRIAN CofficerP4,25524.98$106,290
2026-06-29STEPHENSON BRIAN CofficerP83123.34$19,396
2026-06-26STEPHENSON BRIAN CofficerP10026.39$2,639
2026-06-26STEPHENSON BRIAN CofficerP1,35825.55$34,697
2026-06-26STEPHENSON BRIAN CofficerP4,21224.9$104,879
2026-06-26STEPHENSON BRIAN CofficerP58023.61$13,694
2026-06-26STEPHENSON BRIAN CofficerP58023.61$13,694
2026-06-26STEPHENSON BRIAN CofficerP4,21224.9$104,879
2026-06-26STEPHENSON BRIAN CofficerP1,35825.55$34,697
2026-06-26STEPHENSON BRIAN CofficerP10026.39$2,639
2026-06-24STEPHENSON BRIAN CofficerP10027.77$2,777
2026-06-24STEPHENSON BRIAN CofficerP3,40026.98$91,732
2026-06-24STEPHENSON BRIAN CofficerP3,00025.98$77,940
2026-06-24STEPHENSON BRIAN CofficerP2,89125.22$72,911
2026-06-24STEPHENSON BRIAN CofficerP2,89125.22$72,911
2026-06-24STEPHENSON BRIAN CofficerP3,00025.98$77,940
2026-06-24STEPHENSON BRIAN CofficerP3,40026.98$91,732
2026-06-24STEPHENSON BRIAN CofficerP10027.77$2,777
2026-06-23STEPHENSON BRIAN CofficerP6,83624.12$164,884
2026-06-23STEPHENSON BRIAN CofficerP1,96924.84$48,910
2026-06-23STEPHENSON BRIAN CofficerP42525.91$11,012
2026-06-23STEPHENSON BRIAN CofficerP6,83624.12$164,884
2026-06-23STEPHENSON BRIAN CofficerP1,96924.84$48,910
2026-06-23STEPHENSON BRIAN CofficerP42525.91$11,012
2026-06-22STEPHENSON BRIAN CofficerP1,11820.82$23,277
2026-06-22STEPHENSON BRIAN CofficerP1,58322.4$35,459
2026-06-22STEPHENSON BRIAN CofficerP3,32923.28$77,499
2026-06-22STEPHENSON BRIAN CofficerP35623.95$8,526
2026-06-22STEPHENSON BRIAN CofficerP1,79720.23$36,353
2026-06-22Parikh Anand KirandirectorM45,2521.16$52,492
2026-06-22Parikh Anand KirandirectorM8,2131.16$9,527
2026-06-22Parikh Anand KirandirectorP2,80619.76$55,447
2026-06-22STEPHENSON BRIAN CofficerP1,79720.23$36,353
2026-06-22STEPHENSON BRIAN CofficerP1,11820.82$23,277
2026-06-22STEPHENSON BRIAN CofficerP1,58322.4$35,459
2026-06-22STEPHENSON BRIAN CofficerP3,32923.28$77,499
2026-06-22STEPHENSON BRIAN CofficerP35623.95$8,526
2026-06-22Parikh Anand KirandirectorP2,80619.76$55,447
2026-06-22Parikh Anand KirandirectorM45,2521.16$52,492
2026-06-22Parikh Anand KirandirectorM8,2131.16$9,527
2026-06-15Parikh Anand KirandirectorC761,428——
2026-06-15Hahn Stephen M.directorC44,763——
2026-06-15Parikh Anand KirandirectorC761,428——
2026-06-15Hahn Stephen M.directorC44,763——
2026-06-01Cambrian BioPharma Incten percent ownerS24,52420$490,480
2026-06-01Cambrian BioPharma Incten percent ownerS47621.14$10,063

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings